Navigation Links
Fudan-Cinpathogen Study Shows Chronic Lymphoid Neoplasms are More Common in Shanghai Than Thought
Date:8/4/2008

A paper published in the International Journal of Hematology by scientists from the Fudan-Cinpathogen Clinical and Molecular Research Center at Fudan University, Shanghai, in collaboration with the University of Colorado, and Cincinnati Children's Hospital indicates that specific subtypes of chronic lymphoid neoplasms are not as rare in China as has been previously reported. Diagnosis and classification were performed by a single central laboratory in Shanghai according to WHO (2001) criteria making it largest prospective case series of lymphoid neoplasms in China published to date.

Shanghai, China (PRWEB) August 4, 2008 -- http://www.springerlink.com/content/r1623x466m24237r/ [A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai, China] published online in the International Journal of Hematology shows significant differences in frequency of subtypes of lymphoma and other lymphoid neoplasms between China and the West. The report also reveals that chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), previously thought to be rare in China, is more common than suggested in earlier reports.

This publication is eighth in a series reporting research conducted by Cinpathogen scientists in collaboration with Fudan University, the University of Colorado, and Cincinnati Children's Hospital, that characterizes the features and frequency of hematopoietic disorders in China.

"Our study has increased medical knowledge and allowed us to help individual patients by sharing technological advancements," said Dr. Richard D. Irons, Cinpathogen CEO and the principal investigator of the project. "We are obtaining a better understanding of the prevalence of hematopoietic diseases in China, while at the same time having an impact on people's lives by providing the citizens of Shanghai the same advanced diagnostics that patients at modern Western medical centers receive."

A unique aspect of the 4 year Shanghai study is that diagnosis and classification were performed by a single central laboratory according to WHO (2001) criteria. This month's publication presents the results of the largest prospective case series of lymphoid neoplasms in China published to date. "It serves as an example that high-quality, state-of-the-art research is possible in China," explained Dr. Irons.

Cinpathogen operates the Fudan-Cinpathogen Clinical and Molecular Research Center providing diagnostics to patients from over 30 Shanghai area hospitals and conducting translational research on hematopoietic and lymphoid disorders in China. The Center offers specialized clinical capabilities that meet Western standards in the fields of hematology, molecular pathology, cytogenetics and flow cytometry.

For more information, visit http://www.cinpathogen.com [Cinpathogen's website] or contact our Boulder, Colorado ( 303-381-2543) or Shanghai ( 86-21-5423-7760) offices.

###

Read the full story at http://www.prweb.com/releases/2008/08/prweb1167414.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Tingley Rubber ... Canada to provide its range of unique and advantaged protective solutions to ... that will provide bilingual customer service and marketing support. A new distribution center ...
(Date:2/8/2016)... (PRWEB) , ... February 08, ... ... and security executive networking and relationship-marketing firm, announced today that nominations will ... Information Security Executive® (ISE®) West Awards. , Awards include the Information ...
(Date:2/8/2016)... ... February 08, 2016 , ... GrassrootsHealth published data from its ... 2 diabetes in the GrassrootsHealth cohort with substantially higher vitamin D levels than ... public health,” states Carole Baggerly, Director of GrassrootsHealth, “the safety and benefits ...
(Date:2/8/2016)... ... February 08, 2016 , ... The schedule is ... this country. The AutismOne 2016 Conference, which is being held May 25-29 at the ... hear elsewhere about helpful interventions and causes of chronic illness in children. , Very ...
(Date:2/7/2016)... ... February 07, 2016 , ... Dr. Todd ... to his medical and surgical expertise. Technically known as deoxycholic acid or previously ... as a non-surgical alternative for reduction of fat below the chin (aka the ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016  The University of ... announced today that, as part of the development ... of the first hospitals in the U.S. to start ... Muraszko , M.D., U-M,s chair of neurosurgery. ... neurosurgery. --> The BrightMatter technology from ...
(Date:2/8/2016)... CITY, Calif., Feb. 8, 2016  Aoxing Pharmaceutical Company, Inc. (NYSE ... fiscal year 2016, ended December 31, 2015, the Company achieved ... recorded in the same quarter in fiscal 2015. ... in Q2 of fiscal year 2016 was $2,068,635, or $.03 ... or $.01 per share, in the Q2 of fiscal year ...
(Date:2/8/2016)... Feb. 8, 2016 ... of the "Label-Free Detection Market by ... 2020" report to their offering. ... addition of the "Label-Free Detection Market ... to 2020" report to their offering. ...
Breaking Medicine Technology: